BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24418290)

  • 1. Interleukin-1 blockade in rheumatoid arthritis and heart failure: a missed opportunity?
    Abbate A; Canada JM; Van Tassell BW; Wise CM; Dinarello CA
    Int J Cardiol; 2014 Feb; 171(3):e125-6. PubMed ID: 24418290
    [No Abstract]   [Full Text] [Related]  

  • 2. TNF-alpha antagonists and other recombinant proteins for the treatment of rheumatoid arthritis.
    Brasington R
    J Hand Surg Am; 2009 Feb; 34(2):349-50. PubMed ID: 19135810
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interleukin-1 inhibitors: a new alternative for the treatment of rheumatoid polyarthritis].
    Gabay C
    Rev Med Suisse Romande; 2000 Jun; 120(6):529-33. PubMed ID: 11014098
    [No Abstract]   [Full Text] [Related]  

  • 4. Anakinra and its rapidly expanding role in management of nonarthritic systemic disorders.
    Kapoor S
    J Rheumatol; 2009 Feb; 36(2):446; author reply 447. PubMed ID: 19208574
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.
    Cohen SB
    Rheum Dis Clin North Am; 2004 May; 30(2):365-80, vii. PubMed ID: 15172046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of rheumatic diseases: current status and future prospective. Topics: III. Biological drugs; 4. Interleukin-1 inhibitor].
    Yamasaki S; Kawakami A
    Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2985-90. PubMed ID: 22175142
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of the IL-1 receptor antagonist, anakinra, for the treatment of diffuse anterior scleritis in rheumatoid arthritis. Report of two cases.
    Botsios C; Sfriso P; Ostuni PA; Todesco S; Punzi L
    Rheumatology (Oxford); 2007 Jun; 46(6):1042-3. PubMed ID: 17449489
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis?
    Gabriel SE
    Arthritis Rheum; 2008 Mar; 58(3):637-40. PubMed ID: 18311805
    [No Abstract]   [Full Text] [Related]  

  • 9. [When are "biologics" indicated?].
    MMW Fortschr Med; 2006 Apr; 148(17):10. PubMed ID: 16711479
    [No Abstract]   [Full Text] [Related]  

  • 10. Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
    Listing J; Strangfeld A; Kekow J; Schneider M; Kapelle A; Wassenberg S; Zink A
    Arthritis Rheum; 2008 Mar; 58(3):667-77. PubMed ID: 18311816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indications of anakinra].
    Chauffier K; London J; Beaudouin C; Fautrel B
    Presse Med; 2009 May; 38(5):799-807. PubMed ID: 19278814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade.
    Redlich K; Schett G; Steiner G; Hayer S; Wagner EF; Smolen JS
    Arthritis Rheum; 2003 Dec; 48(12):3308-19. PubMed ID: 14673982
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment, management, and monitoring of established rheumatoid arthritis.
    Bingham CO; Miner MM
    J Fam Pract; 2007 Oct; 56(10 Suppl Rapid):S1-7; quiz S8. PubMed ID: 17949607
    [No Abstract]   [Full Text] [Related]  

  • 14. The 'alphabet' of rheumatoid arthritis treatment.
    Capriotti T
    Medsurg Nurs; 2004 Dec; 13(6):420-8. PubMed ID: 15714747
    [No Abstract]   [Full Text] [Related]  

  • 15. Lowering interleukin-1 activity with anakinra improves myocardial deformation in rheumatoid arthritis.
    Ikonomidis I; Tzortzis S; Lekakis J; Paraskevaidis I; Andreadou I; Nikolaou M; Kaplanoglou T; Katsimbri P; Skarantavos G; Soucacos P; Kremastinos DT
    Heart; 2009 Sep; 95(18):1502-7. PubMed ID: 19482847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine blocker licensed for relief of rheumatoid arthritis symptoms.
    Am J Health Syst Pharm; 2002 Feb; 59(3):225-6. PubMed ID: 11862629
    [No Abstract]   [Full Text] [Related]  

  • 17. [State-of-the-art biological therapy of rheumatoid arthritis].
    Sigidin IaA; Lukina GV
    Vestn Ross Akad Med Nauk; 2008; (6):19-24. PubMed ID: 18652199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Cytokine antagonists].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(5):201-3. PubMed ID: 12557112
    [No Abstract]   [Full Text] [Related]  

  • 19. IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission.
    Ryan JG; de Koning HD; Beck LA; Booty MG; Kastner DL; Simon A
    J Allergy Clin Immunol; 2008 Jan; 121(1):260-2. PubMed ID: 17936890
    [No Abstract]   [Full Text] [Related]  

  • 20. Rheumatoid arthritis and heart failure.
    Bhatia GS; Davis RC
    Am J Med; 2004 Nov; 117(9):709; author reply 709. PubMed ID: 15501214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.